Pricing Log in Create free account

Assembly Biosciences, Inc. (ASMB) vs CorMedix Inc (CRMD)

Assembly Biosciences, Inc. and CorMedix Inc are both Biotechnology companies. Assembly Biosciences, Inc. and CorMedix Inc are of similar size ($407.6M and $407.2M). Assembly Biosciences, Inc. has negative trailing earnings, so its P/E is not meaningful; CorMedix Inc trades at 2.2×. CorMedix Inc grew revenue faster over the last twelve months: 280.5% against 125.1%. CorMedix Inc has the higher net margin (40.5% vs −0.06%) and the higher return on invested capital (38.8% vs 0.00%). Across the 18 metrics below, CorMedix Inc leads on 15 and Assembly Biosciences, Inc. on 3.

Valuation

Metric ASMB CRMD Biotechnology median
P/E n/m 2.20 10.60
P/S 5.13 0.90 9.40
P/B 1.26 0.90 2.13
Price to free cash flow n/m 1.66 25.18
EV/EBITDA n/m 1.20 0.66
EV/Sales 0.85 0.66 9.02
Earnings yield (0.79%) 45.47% (32.88%)
Free cash flow yield (10.05%) 60.23% (23.13%)

Profitability

Metric ASMB CRMD Biotechnology median
Gross margin 100.00% 82.78% 68.51%
Operating margin (11.75%) 46.95% 0.00%
Net margin (0.06%) 40.49% 0.00%
Free cash flow margin (51.53%) 54.17% 0.00%
Return on equity (0.03%) 54.93% (51.96%)
Return on assets (0.02%) 32.36% (46.06%)
Return on invested capital 0.00% 38.84% 0.00%

Growth

Metric ASMB CRMD Biotechnology median
Revenue growth (TTM) 125.12% 280.50% 6.76%
EPS growth (last fiscal year) 91.78% 780.00% 29.88%
Revenue growth, 5-year CAGR 35.27% 305.79% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB CRMD Biotechnology median
Debt to equity 0.00 0.32 0.00
Current ratio 13.99 2.56 4.97
Net debt to EBITDA 17.31 (0.02) 1.01

Dividend

Metric ASMB CRMD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ASMB CRMD Biotechnology median
Market cap 407.22m 407.64m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack